FDA authorizes Abbott's wearable to monitor ketone and glucose in diabetes patients

Aug 25 (Reuters) – The U.S. Food and Drug Administration said on Tuesday it authorized Abbott Laboratories' glucose monitor, making it the first device that continuously monitors both ketone levels

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)